Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 07:58am US/Eastern

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

React to this article
04:52p AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Terminati..
01/27 AUXILIUM PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders, ..
01/27 AUXILIUM PHARMACEUTICALS : Announces Results from Special Meeting of Stockholder..
01/21DJEndo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
01/21 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
01/16 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
2014 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
2014 AUXILIUM PHARMACEUTICALS : Sobi's Xiapex receives positive opinion by CHMP for t..
2014 AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
2014 AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes